IQCJ-SCHIP1, a novel fusion transcript encoding a calmodulin-binding IQ motif protein

Biochemical and Biophysical Research Communications

Volumn 350, Issue 4, 2006, Pages 890-899

  Kwaśnicka Crawford, Dorota A ^a,c   Carson, Andrew R ^a   Scherer, Stephen W ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c York University   (Canada)

Author keywords

Autism; Calmodulin; Language disorder; Neurofibromatosis type 2; Paracentric inversion; Schwannomin interacting protein

Indexed keywords

ACTIN; CALMODULIN BINDING PROTEIN; GENOMIC DNA; MERLIN; NEUROFIBROMATOSIS TYPE 2 PROTEIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; AUTISM; CELL DIFFERENTIATION; CELL LINE; CHROMOSOME 3Q; CONTROLLED STUDY; EXON; FETUS; FUSION GENE; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; LANGUAGE DISABILITY; MOLECULAR WEIGHT; NEURITE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; RAT;

AMINO ACID MOTIFS; CALMODULIN-BINDING PROTEINS; OPEN READING FRAMES; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 33750075169     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.09.136     Document Type: Article

References (34)

1. Okuda S., Katayama T., Kawashima S., Goto S., and Kanehisa M. ODB: a database of operons accumulating known operons across multiple genomes. Nucleic Acids Res. 34 (2006) D358-D362
2. Kwasnicka D.A., Krakowiak A., Thacker C., Brenner C., and Vincent S.R. Coordinate expression of NADPH-dependent flavin reductase, Fre-1, and Hint-related 7meGMP-directed hydrolase, DCS-1. J. Biol. Chem. 278 (2003) 39051-39058
3. Parra G., Reymond A., Dabbouseh N., Dermitzakis E.T., Castelo R., Thomson T.M., Antonarakis S.E., and Guigo R. Tandem chimerism as a means to increase protein complexity in the human genome. Genome Res. 16 (2006) 37-44
4. Akiva P., Toporik A., Edelheit S., Peretz Y., Diber A., Shemesh R., Novik A., and Sorek R. Transcription-mediated gene fusion in the human genome. Genome Res. 16 (2006) 30-36
5. Thomson T.M., Lozano J.J., Loukili N., Carrio R., Serras F., Cormand B., Valeri M., Diaz V.M., Abril J., Burset M., Merino J., Macaya A., Corominas M., and Guigo R. Fusion of the human gene for the polyubiquitination coeffector UEV1 with Kua, a newly identified gene. Genome Res. 10 (2000) 1743-1756
6. Pradet-Balade B., Medema J.P., Lopez-Fraga M., Lozano J.C., Kolfschoten G.M., Picard A., Martinez A.C., Garcia-Sanz J.A., and Hahne M. An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein. EMBO J. 21 (2002) 5711-5720
7. Goutebroze L., Brault E., Muchardt C., Camonis J., and Thomas G. Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins. Mol. Cell Biol. 20 (2000) 1699-1712
8. Gusella J.F., Ramesh V., MacCollin M., and Jacoby L.B. Merlin: the neurofibromatosis 2 tumor suppressor. Biochim. Biophys. Acta 1423 (1999) M29-M36
9. Kwasnicka-Crawford D.A., Carson A.R., Roberts W., Summers A.M., Rehnstrom K., Jarvela I., and Scherer S.W. Characterization of a novel cation transporter ATPase gene (ATP13A4) interrupted by 3q25-q29 inversion in an individual with language delay. Genomics 86 (2005) 182-194
10. Lichter P., Cremer T., Borden J., Manuelidis L., and Ward D.C. Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries. Hum. Genet. 80 (1988) 224-234
11. Bieche I., Laurendeau I., Tozlu S., Olivi M., Vidaud D., Lidereau R., and Vidaud M. Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. Cancer Res. 59 (1999) 2759-2765
12. Martin T.F., and Grishanin R.N. PC12 cells as a model for studies of regulated secretion in neuronal and endocrine cells. Methods Cell Biol. 71 (2003) 267-286
13. Lewin G.R. Neurotrophins and the specification of neuronal phenotype. Philos. Tr. R. Soc. B 351 (1996) 405-411
14. Chan J.R., Watkins T.A., Cosgaya J.M., Zhang C., Chen L., Reichardt L.F., Shooter E.M., and Barres B.A. NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes. Neuron 43 (2004) 183-191
15. McClatchey A.I., Saotome I., Ramesh V., Gusella J.F., and Jacks T. The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation. Genes Dev. 11 (1997) 1253-1265
16. Kohler D., Struchholz S., and Bahler M. The two IQ-motifs and Ca2+/calmodulin regulate the rat myosin 1d ATPase activity. FEBS J. 272 (2005) 2189-2197
17. Rhoads A.R., and Friedberg F. Sequence motifs for calmodulin recognition. FASEB J. 11 (1997) 331-340
18. Alexander K.A., Wakim B.T., Doyle G.S., Walsh K.A., and Storm D.R. Identification and characterization of the calmodulin-binding domain of neuromodulin, a neurospecific calmodulin-binding protein. J. Biol. Chem. 263 (1988) 7544-7549
19. Baudier J., Deloulme J.C., Van Dorsselaer A., Black D., and Matthes H.W. Purification and characterization of a brain-specific protein kinase C substrate, neurogranin (p17). Identification of a consensus amino acid sequence between neurogranin and neuromodulin (GAP43) that corresponds to the protein kinase C phosphorylation site and the calmodulin-binding domain. J. Biol. Chem. 266 (1991) 229-237
20. Avwenagha O., Campbell G., and Bird M.M. Distribution of GAP-43, beta-III tubulin and F-actin in developing and regenerating axons and their growth cones in vitro, following neurotrophin treatment. J. Neurocytol. 32 (2003) 1077-1089
21. Donovan S.L., Mamounas L.A., Andrews A.M., Blue M.E., and McCasland J.S. GAP-43 is critical for normal development of the serotonergic innervation in forebrain. J. Neurosci. 22 (2002) 3543-3552
22. Wehrle R., Caroni P., Sotelo C., and Dusart I. Role of GAP-43 in mediating the responsiveness of cerebellar and precerebellar neurons to axotomy. Eur. J. Neurosci. 13 (2001) 857-870
23. Alvarez-Bolado G., Rodriguez-Sanchez P., Tejero-Diez P., Fairen A., and Diez-Guerra F.J. Neurogranin in the development of the rat telencephalon. Neuroscience 73 (1996) 565-580
24. Evans L.L., Lee A.J., Bridgman P.C., and Mooseker M.S. Vesicle-associated brain myosin-V can be activated to catalyze actin-based transport. J. Cell Sci. 111 Pt 14 (1998) 2055-2066
25. Courchesne E., Karns C.M., Davis H.R., Ziccardi R., Carper R.A., Tigue Z.D., Chisum H.J., Moses P., Pierce K., Lord C., Lincoln A.J., Pizzo S., Schreibman L., Haas R.H., Akshoomoff N.A., and Courchesne R.Y. Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 57 (2001) 245-254
26. Carper R.A., and Courchesne E. Localized enlargement of the frontal cortex in early autism. Biol. Psychiatry 57 (2005) 126-133
27. Carper R.A., Moses P., Tigue Z.D., and Courchesne E. Cerebral lobes in autism: early hyperplasia and abnormal age effects. Neuroimage 16 (2002) 1038-1051
28. De Fosse L., Hodge S.M., Makris N., Kennedy D.N., Caviness Jr. V.S., McGrath L., Steele S., Ziegler D.A., Herbert M.R., Frazier J.A., Tager-Flusberg H., and Harris G.J. Language-association cortex asymmetry in autism and specific language impairment. Ann. Neurol. 56 (2004) 757-766
29. Watkins K.E., Vargha-Khadem F., Ashburner J., Passingham R.E., Connelly A., Friston K.J., Frackowiak R.S., Mishkin M., and Gadian D.G. MRI analysis of an inherited speech and language disorder: structural brain abnormalities. Brain 125 (2002) 465-478
30. Belton E., Salmond C.H., Watkins K.E., Vargha-Khadem F., and Gadian D.G. Bilateral brain abnormalities associated with dominantly inherited verbal and orofacial dyspraxia. Hum. Brain Mapp. 18 (2003) 194-200
31. Herbert M.R., Harris G.J., Adrien K.T., Ziegler D.A., Makris N., Kennedy D.N., Lange N.T., Chabris C.F., Bakardjiev A., Hodgson J., Takeoka M., Tager-Flusberg H., and Caviness Jr. V.S. Abnormal asymmetry in language association cortex in autism. Ann. Neurol. 52 (2002) 588-596
32. Kleinjan D.A., and van Heyningen V. Long-range control of gene expression: emerging mechanisms and disruption in disease. Am. J. Hum. Genet. 76 (2005) 8-32
33. Auranen M., Varilo T., Alen R., Vanhala R., Ayers K., Kempas E., Ylisaukko-Oja T., Peltonen L., and Jarvela I. Evidence for allelic association on chromosome 3q25-27 in families with autism spectrum disorders originating from a subisolate of Finland. Mol. Psychiatry 8 (2003) 879-884
34. Auranen M., Vanhala R., and Jarvela I. First gene connected to autism spectrum disorders has been found. Duodecim 116 (2000) 2185-2187